A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

Clinical trial NCT04532281 · RECRUITING

Trial details

NCT number: NCT04532281
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non-Hodgkin Lymphoma of Soft Tissue

Start date: 2020-11-01
Primary completion: 2023-11-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.